{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T05:39:22Z","timestamp":1792474762895,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.clgc.2020.09.007","type":"journal-article","created":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T13:50:33Z","timestamp":1602597033000},"page":"e184-e192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Stage Migration for Upper Tract Urothelial Cell Carcinoma"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9537-4619","authenticated-orcid":false,"given":"Asef","family":"Aziz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed J.","family":"Raza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4116-3343","authenticated-orcid":false,"given":"Facundo","family":"Davaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"May","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2587-0865","authenticated-orcid":false,"given":"Zachary","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clgc.2020.09.007_bib1","first-page":"7","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clgc.2020.09.007_bib3","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ejrad.2017.10.021","article-title":"Upper tract urothelial cancer","volume":"98","author":"Froemming","year":"2018","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.clgc.2020.09.007_bib4","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00345-016-1928-x","article-title":"Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC)","volume":"35","author":"Soria","year":"2017","journal-title":"World J Urol"},{"key":"10.1016\/j.clgc.2020.09.007_bib6","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/cncr.23518","article-title":"Renal cell cancer stage migration: analysis of the National Cancer Data Base","volume":"113","author":"Kane","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.clgc.2020.09.007_bib7","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1002\/cncr.24147","article-title":"Surveillance of urothelial carcinoma: stage and grade migration, 1993-2005 and survival trends, 1993-2000","volume":"115","author":"David","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.clgc.2020.09.007_bib8","first-page":"1523","article-title":"Upper tract urothelial neoplasms: incidence and survival during the last 2 decades","volume":"164","author":"Munoz","year":"2000","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.clgc.2020.09.007_bib9","first-page":"93","article-title":"The eighth edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clgc.2020.09.007_bib10","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1056\/NEJM198506203122504","article-title":"The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer","volume":"312","author":"Feinstein","year":"1985","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clgc.2020.09.007_bib11","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/j.1464-410X.2010.09675.x","article-title":"Incidence and survival of patients with carcinoma of the ureter and renal pelvis in the USA, 1973-2005","volume":"107","author":"Raman","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.clgc.2020.09.007_bib12","doi-asserted-by":"crossref","first-page":"236.e223","DOI":"10.1016\/j.urolonc.2015.12.002","article-title":"Trends in the utilization of imaging for upper tract urothelial carcinoma","volume":"34","author":"Mohapatra","year":"2016","journal-title":"Urol Oncol"},{"key":"10.1016\/j.clgc.2020.09.007_bib13","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ucl.2018.03.004","article-title":"Upper and lower tract urothelial imaging using computed tomography urography","volume":"45","author":"Raman","year":"2018","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.clgc.2020.09.007_bib14","first-page":"690","article-title":"Phase II trial of neoadjuvant systemic chemotherapy followed by extirpative surgery in patients with high grade upper tract urothelial carcinoma","volume":"203","author":"Margulis","year":"2020","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.clgc.2020.09.007_bib15","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1001\/jamainternmed.2018.4725","article-title":"Trends in emergency department visits and admission rates among US acute care hospitals","volume":"178","author":"Lin","year":"2018","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.clgc.2020.09.007_bib16","doi-asserted-by":"crossref","first-page":"4929","DOI":"10.2147\/CMAR.S180606","article-title":"Microscopic hematuria predicts lower stage in patients with upper tract urothelial carcinoma","volume":"10","author":"Qi","year":"2018","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.clgc.2020.09.007_bib17","first-page":"2473","article-title":"Diagnosis, evaluation and follow-up of asymptomatic microhematuria (AMH) in adults: AUA guideline","volume":"188","author":"Davis","year":"2012","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.clgc.2020.09.007_bib18","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/S0140-6736(17)30786-9","article-title":"The Affordable Care Act: implications for health-care equity","volume":"389","author":"Gaffney","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.clgc.2020.09.007_bib19","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1177\/1756287218805334","article-title":"Advances in the management of upper tract urothelial carcinoma: improved endoscopic management through better diagnostics","volume":"10","author":"Knoedler","year":"2018","journal-title":"Ther Adv Urol"},{"key":"10.1016\/j.clgc.2020.09.007_bib20","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/bju.14020","volume":"121","author":"Necchi","year":"2018","journal-title":"BJU Int"},{"key":"10.1016\/j.clgc.2020.09.007_bib21","first-page":"196","article-title":"Urothelial carcinoma: adjuvant chemotherapy improves outcomes after RNU","volume":"14","author":"Sidaway","year":"2017","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.clgc.2020.09.007_bib22","first-page":"9938","article-title":"Chemotherapy increases survival and downstaging of upper tract urothelial cancer","volume":"26","author":"Davaro","year":"2019","journal-title":"Can J Urol"},{"key":"10.1016\/j.clgc.2020.09.007_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/OTT.S225301","article-title":"Optimal management of upper tract urothelial carcinoma: current perspectives","volume":"13","author":"Leow","year":"2020","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.clgc.2020.09.007_bib24","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.urolonc.2019.05.021","article-title":"The role of adjuvant radiotherapy after surgery for upper and lower urinary tract urothelial carcinoma: a systematic review","volume":"37","author":"Iwata","year":"2019","journal-title":"Urol Oncol"},{"key":"10.1016\/j.clgc.2020.09.007_bib25","doi-asserted-by":"crossref","first-page":"P1268","DOI":"10.1016\/S0140-6736(20)30415-3","article-title":"Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial","volume":"395","author":"Birtle","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.clgc.2020.09.007_bib26","first-page":"1101","article-title":"Efficacy of preoperative chemotherapy for high risk upper tract urothelial carcinoma","volume":"203","author":"Foerster","year":"2020","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.clgc.2020.09.007_bib27","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1016\/j.ejca.2009.06.016","article-title":"Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: a population-based study of 2299 patients","volume":"45","author":"Lughezzani","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clgc.2020.09.007_bib28","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/cncr.24135","article-title":"Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration","volume":"115","author":"Margulis","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.clgc.2020.09.007_bib29","doi-asserted-by":"crossref","DOI":"10.1177\/1756287218815372","article-title":"Contemporary best practice in the management of urothelial carcinomas of the renal pelvis and ureter","volume":"11","author":"Bianconi","year":"2019","journal-title":"Ther Adv Urol"},{"key":"10.1016\/j.clgc.2020.09.007_bib30","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1111\/cas.14000","article-title":"Diagnostic potential of TERT promoter and FGFR3 mutations in urinary cell-free DNA in upper tract urothelial carcinoma","volume":"110","author":"Hayashi","year":"2019","journal-title":"Cancer Sci"},{"key":"10.1016\/j.clgc.2020.09.007_bib31","doi-asserted-by":"crossref","first-page":"e0201256","DOI":"10.1371\/journal.pone.0201256","article-title":"STAT3 expression is a prognostic marker in upper urinary tract urothelial carcinoma","volume":"13","author":"Matsuzaki","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.clgc.2020.09.007_bib32","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nrurol.2017.120","article-title":"Immunology: PD-1 and PD-L1 prognostic in UTUC","volume":"14","author":"Stone","year":"2017","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.clgc.2020.09.007_bib33","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.eururo.2017.12.018","article-title":"Updates in the eighth edition of the tumor\u2013node\u2013metastasis staging classification for urologic cancers","volume":"73","author":"Paner","year":"2018","journal-title":"Eur Urol"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767320302275?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767320302275?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:33:22Z","timestamp":1761564802000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767320302275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S1558767320302275"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2020.09.007","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stage Migration for Upper Tract Urothelial Cell Carcinoma","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2020.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}